Discover the latest in GLP-1 weight loss, including the new Wegovy 7.2 mg injection and oral options. Learn how HomeRemedy supports your metabolic health journey.
HomeRemedy Health Team
Licensed Nurse Practitioner
The landscape of metabolic health is shifting rapidly. As we navigate 2026, medical weight loss has become more personalized and effective than ever before. With the recent FDA approval of high-dose Wegovy 7.2 mg and the introduction of oral semaglutide, patients in Miami-Dade now have more robust tools to achieve their health goals. At HomeRemedy, we believe that long-term success isn't just about the medication—it's about the comprehensive care, nutritional support, and metabolic monitoring that accompanies your journey.
In March 2026, the FDA approved a significant expansion for weight management protocols: the high-dose Wegovy 7.2 mg weekly injection. Validated by the rigorous STEP UP trials of 2025, this dosage is specifically designed for patients who have already successfully tolerated the 2.4 mg maintenance dose but require an additional boost in their metabolic health outcomes. Clinical data from the trials confirmed that this higher dose promotes enhanced body composition shifts while maintaining a favorable semaglutide safety profile.
Furthermore, December 2025 saw the formal approval of Oral Wegovy (25 mg daily). This provides an innovative, needle-free path for chronic weight management, offering increased accessibility for those who prefer an oral regimen over GLP-1 injections. Understanding the bioavailability of these treatments is crucial, which is why our mobile healthcare team works closely with you to determine the most effective delivery method for your specific lifestyle.
One of the most common questions we receive at our weight loss clinic in Miami involves the process of medication adjustment. GLP-1 titration remains the gold standard for success. The standard 5-step process begins at 0.25 mg weekly, allowing your body to acclimate slowly to the medication and minimizing gastrointestinal side effects. Attempting to accelerate this process can lead to discomfort, which is why our medical staff monitors your progress closely.
Research underscores a vital truth: semaglutide is a tool for long-term health, not a temporary fix. Studies indicate that patients who discontinue treatment often regain approximately two-thirds of their lost weight within one year. This highlights the importance of weight maintenance strategies, including consistent nutritional guidance and metabolic support, which are core pillars of our mobile home healthcare services.
While medication handles the biological regulation of appetite and metabolism, your body requires cellular support to thrive during weight loss. IV nutrient therapy has become a cornerstone of our practice. For patients dealing with malabsorption issues or those seeking to bolster their immune support and recovery, IV therapy provides immediate access to essential vitamins and electrolytes. When combined with traditional GLP-1 weight loss treatments, patients often report improved energy levels and a faster return to baseline activity after strenuous exercise.
Whether you are looking for semaglutide near me or seeking a comprehensive plan involving tirzepatide or Ozempic, HomeRemedy brings expert medical weight loss directly to your door. We remove the stress of commuting to a clinic, providing professional consultations, blood panels, and treatment administration in the comfort of your home. If you are ready to take control of your metabolic health, our team is here to guide you with evidence-based, compassionate care.
Your journey toward sustainable body composition starts with a conversation. Don't let distance or scheduling challenges prevent you from accessing the latest in medical weight loss technology. Contact HomeRemedy today to explore how our personalized mobile services can help you achieve your goals.
Ready to transform your health? Call us at (786) 390-0956 or schedule your mobile consultation online today!
Ready to take action?
Book a free consultation with one of our licensed nurse practitioners — we come to you.
Book Free Consultation →Discover the latest on the new 7.2 mg semaglutide approval, the STEP UP trial results, and how it impacts GLP-1 weight loss treatments in Miami-Dade County today.
GLP-1 Weight LossDiscover the future of GLP-1 weight loss in 2025. Explore emerging peptide therapies like VK2735 and Eloralintide versus traditional lipotropic injections.